Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen.
The concentration of plasma angiotensinogen increases upon induction of inflammation. Studies were carried out using serum samples collected from mice and rats after injection of lipopolysaccharide (LPS) to determine whether interleukin-6 (IL-6) is a mediator responsible for the inflammation-induced increase of angiotensinogen synthesis in liver cells. Serum collected from mice or rats 2 and 4 hr after injection of LPS contained a factor that stimulated [35S]methionine incorporation into angiotensinogen newly synthesized by rat hepatoma H4IIEC3 (H4) cells. Assay of IL-6 using an IL-6-dependent murine hybridoma, MH60.BSF2 cells, showed the presence of IL-6-like activity in sera of mice or rats 2 and 4 hr after injection of LPS. Anti-mouse IL-6 monoclonal antibody completely inhibited not only the IL-6-like activity present in LPS-treated mouse serum but also the ability of the serum to stimulate angiotensinogen synthesis of H4 cells. These results suggest that increased synthesis of angiotensinogen in the liver after induction of inflammation is mediated by IL-6, a cytokine important in immune reactions and the hepatic acute-phase response.
Takano
M
M
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kobe-Gakuin University, Japan.
Itoh
N
N
Yayama
K
K
Yamano
M
M
Ohtani
R
R
Okamoto
H
H
D000808:Angiotensinogen / Q000096:biosynthesis*; D000818:Animals; D000906:Antibodies / Q000276:immunology; D001769:Blood; D007249:Inflammation / Q000097:blood* / Q000139:chemically induced; D015850:Interleukin-6 / Q000097:blood / Q000276:immunology / Q000502:physiology*; D008070:Lipopolysaccharides; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D051381:Rats; D017207:Rats, Sprague-Dawley; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000906:Antibodies; D015850:Interleukin-6; D008070:Lipopolysaccharides; D000808:Angiotensinogen